[1] [3] Tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist with similar clinical effects
It's also one of the body's most powerful fat-soluble antioxidants, protecting cell membranes, LDL particles, and mitochondrial DNA from oxidative damage
Patients should be educated about signs and symptoms of potential serious adverse effects, including pancreatitis, gallbladder disease, and severe hypoglycemia if receiving concurrent antidiabetic therapy
All the ingredientssuch as L-Carnitine, EGCG, Chromium, and Chlorogenic Acidhave been widely studied for metabolic health and fat-burning
Access this article Similar content being viewed by others References Papers of particular interest, published recently, have been highlighted as: Of importance Of major importance Pieczenik SR, Neustadt J